FACULTAD DE MEDICINA
Facultad
Paul Sabatier University
Tolosa, FranciaPublicaciones en colaboración con investigadores/as de Paul Sabatier University (12)
2024
2023
-
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study
The Lancet, Vol. 401, Núm. 10374, pp. 347-356
-
A Cooperative Rh/Co-Catalyzed Hydroaminomethylation Reaction for the Synthesis of Terpene Amines
ChemCatChem, Vol. 15, Núm. 13
2022
-
Nickel Nanoparticles Immobilized on Pristine Halloysite: An Outstanding Catalyst for Hydrogenation Processes
ChemCatChem, Vol. 14, Núm. 22
2021
-
Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome
Nature Communications, Vol. 12, Núm. 1
-
Human-lineage-specific genomic elements are associated with neurodegenerative disease and APOE transcript usage
Nature Communications, Vol. 12, Núm. 1
-
Review on the catalytic tri-reforming of methane - Part II: Catalyst development
Applied Catalysis A: General, Vol. 623
2020
-
Regulatory sites for splicing in human basal ganglia are enriched for disease-relevant information
Nature Communications, Vol. 11, Núm. 1
2019
-
Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies
The Lancet Neurology, Vol. 18, Núm. 12, pp. 1091-1102
-
Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson’s disease heritability
npj Parkinson's Disease, Vol. 5, Núm. 1
-
SNCA and mTOR Pathway Single Nucleotide Polymorphisms Interact to Modulate the Age at Onset of Parkinson's Disease
Movement Disorders, Vol. 34, Núm. 9, pp. 1333-1344
2017
-
Trends in net survival from prostate cancer in six European Latin countries: Results from the SUDCAN population-based study
European Journal of Cancer Prevention, Vol. 26, Núm. Trends in cancer net survival in six European Latin Countries: the SUDCAN study, pp. S114-S120